Kate L. Weeks

Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin

Catherine E. Winbanks, Kate L. Weeks, Rachel E. Thomson et al. · The Journal of Cell Biology · 2012 · 214 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

PI3K(p110α) Protects Against Myocardial Infarction-Induced Heart Failure

Ruby C.Y. Lin, Kate L. Weeks, Xiao‐Ming Gao et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2010 · 171 citations

Medicine, Cardiology, Molecular Biology +16

Phosphoinositide 3-Kinase p110α Is a Master Regulator of Exercise-Induced Cardioprotection and PI3K Gene Therapy Rescues Cardiac Dysfunction

Kate L. Weeks, Xiao‐Ming Gao, Xiao‐Jun Du et al. · Circulation Heart Failure · 2012 · 145 citations · Full text

Life Sciences, Cardiology, Physiology +16

Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction

Darnel Prakoso, Miles J. De Blasio, Cheng Xue Qin et al. · Clinical Science · 2017 · 60 citations

Medicine, Cardiology, Pharmacology +15

Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes

Darnel Prakoso, Miles J. De Blasio, Mitchel Tate et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2020 · 47 citations · Full text

Medicine, Cardiology, Pharmacology +16